Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DORIPENEM vs DOXEPIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DORIPENEM vs DOXEPIN: Safety Overview

Metric DORIPENEM DOXEPIN
Total FAERS Reports 239 4,021
Deaths Reported 78 1,613
Death Rate 32.6% 40.1%
Hospitalizations 91 1,091
Average Patient Age 56.2 yrs 49.2 yrs
% Female Patients 35.4% 63.8%
FDA Approval Date Oct 12, 2007 Approved Prior to Jan 1, 1982
Manufacturer N/A Teva Pharmaceuticals USA, Inc.
Route N/A TOPICAL
Marketing Status Discontinued Discontinued